Clinical Trial Update: Treatment of Cutaneous Lupus Erythematosus (CLE) With the 595 nm Flashlamp Pulsed Dye Laser [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a 595 nm flashlamp pulsed dye laser for Cutaneous Lupus Erythematosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Lupus Erythematosus

Drugs mentioned

• 595 nm flashlamp pulsed dye laser

Snippet

Sponsor: University of Pennsylvania | Conditions: Cutaneous Lupus Erythematosus | Phase 2 | Status: COMPLETED